Trial Profile
Phase II trial of Recombinant Asparaginase in adults patients with acute lymphoblastic leukaemia.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Asparaginase (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- 08 Jun 2017 New trial record